Home > Insider Trading > Filing (0001209191-21-030399)

Filing Details

Accession Number:: 0001209191-21-030399
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-05 13:00:00
Reporting Period:: 2021-05-03

Accepted Time:: 2021-05-05 17:14:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1770787	10X Genomics Inc.	TXG	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189140	R John Stuelpnagel	C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2021-05-03	600	$189.25	427,891	No	4	S	Direct
Class A Common Stock	Disposition	2021-05-03	1,320	$190.53	426,571	No	4	S	Direct
Class A Common Stock	Disposition	2021-05-03	2,880	$191.83	423,691	No	4	S	Direct
Class A Common Stock	Disposition	2021-05-03	2,200	$192.54	421,491	No	4	S	Direct
Class A Common Stock	Disposition	2021-05-03	300	$193.84	421,191	No	4	S	Direct
Class A Common Stock	Disposition	2021-05-03	100	$194.90	421,091	No	4	S	Direct
Class A Common Stock	Disposition	2021-05-03	100	$198.09	420,991	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $189.09 to $189.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $190.13 to $191.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $191.19 to $192.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $192.26 to $193.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $193.38 to $194.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.